It has been a better year for the Russell 2000 and the small-caps it represents.
Investors don't always need to pile into bonds when afraid of weak global growth.
Investors who want exposure to small caps: Now is the time to get in.
When there is real market turmoil, the smaller names usually are damaged more than their large-cap cousins.
The idea here is to buy something before everyone else wants to.
Shares of Iovance Biotherapeutics and Reata Pharmaceuticals took it on the chin in the fourth quarter, but both companies seem ready to reward shareholders for their patience.
These rules can help investors who are digging through the rubble that 2018 left behind in the biotech sector.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.